Abstract:Homozygous DNAJC12 c.79-2A>G (p. V27Wfs*14) loss-of-function mutations were first reported as a cause of young-onset Parkinson's disease. However, bi-allelic autosomal recessive pathogenic variants in DNAJC12 may lead to an alternative constellation of neurological features, including infantile dystonia, developmental delay, intellectual disability and neuropsychiatric disorders. DNAJC12 is understood to co-chaperone aromatic amino acid hydroxylases to foster the synthesis of biogenic amines. In vitro, we discover overexpressed DNAJC12 forms a complex with guanine triphosphate cyclohydrolase 1 (GCH1), the rate-limiting enzyme in the synthesis of tetrahydrobiopterin, a cofactor paramount for biogenic amines synthesis. We also confirm DNAJC12's interaction with tyrosine (TH) and tryptophan hydroxylase (TPH), which are rate-limiting enzymes for synthesis of biogenic amines dopamine (DA) and serotonin (5-HT). In-vitro knock-down of DNAJC12 with a siRNA destabilizes the DNAJC12-TH-GCH1 complex, reducing GCH1 levels, whereas reciprocal overexpression of both TH and GCH1 increases endogenous DNAJC12, alluding to the significance of modulating the DNAJC12-TH-GCH1 complex as a therapy for DNAJC12 and other biogenic amine disorders. We extend these investigations to a Cre-conditional knock-out mice (cDKO) in which loxP sites flanking Dnajc12 exon 2 enable its excision by cre-recombinase. With germline Cre expression, we have created a constitutive Dnajc12 knock-out (DKO). DKO mice exhibit reduced locomotion/ exploratory behavior at 3 months in automated open-field testing, accompanied by increased plasma phenylalanine which is a cardinal feature of patients with pathogenic DNAJC12 variants. In striatal tissue, total DA and 5-HT, their metabolites, and electrically-evoked DA release are all reduced. Biochemical alterations in synaptic proteins are also apparent, with enhanced phosphorylation of Th pSer31 and pSer40 reflecting biological compensation. Most immediately, cDKO and DKO mice present models to develop and refine therapeutic approaches for biogenic amines disorders, including dystonia and parkinsonism. They will also enable the pleiotropic functions of biogenic amines (including DA), usually synthesized in the brain or periphery, to be separated.

Dopamine D(1) and D(2) receptors in the forebrain of dystonia musculorum mutant mice: an autoradiographic survey in relation to dopamine contents

Dopamine D1 Receptor Mutant Mice Are Deficient in Striatal Expression of Dynorphin and in Dopamine-Mediated Behavioral Responses

Impaired striatal D2 receptor function leads to enhanced GABA transmission in a mouse model of DYT1 dystonia

Alterations in Dopamine Release but Not Dopamine Autoreceptor Function in Dopamine D3 Receptor Mutant Mice

Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors.

Subtle microstructural changes of the cerebellum in a knock-in mouse model of DYT1 dystonia

Striatal parvalbumin interneurons, not cholinergic interneurons, are activated in a mouse model of cerebellar dystonia

Decreased dopamine receptor 1 activity and impaired motor-skill transfer in Dyt1 ΔGAG heterozygous knock-in mice

Dopamine D3 Receptor Mutant and Wild-Type Mice Exhibit Identical Responses to Putative D3 Receptor-Selective Agonists and Antagonists.

Alterations In Dopamine Neurotransmission Produced By Genetic Knockouts Of Dopamine D1 Receptors

Behavioral and Electrophysiological Characterization of Dyt1 Heterozygous Knockout Mice

Dopamine D2L Receptor Deficiency Alters Neuronal Excitability and Spine Formation in Mouse Striatum

Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M <sub>4</sub> muscarinic acetylcholine receptor knockout mice

Cellular Responses to Psychomotor Stimulant and Neuroleptic Drugs Are Abnormal in Mice Lacking the D1 Dopamine Receptor

Dose-response analysis of locomotor activity and stereotypy in dopamine D3 receptor mutant mice following acute amphetamine.

Assessment Of Dopamine D3 Receptor Function Using D3 Receptor Knockout Mice

Lesions Of Mouse Striatum Induced By 6-Hydroxydopamine Differentially Alter The Density, Rate Of Synthesis, And Level Of Gene-Expression Of D-1 And D-2 Dopamine-Receptors

Elimination of Cocaine-Induced Hyperactivity and Dopamine-Mediated Neurophysiological Effects in Dopamine D1 Receptor Mutant Mice

Molecular and Behavioral Phenotypes Caused by Selective Disruption of M4 Muscarinic Acetylcholine Receptors in D1 Dopamine Receptor‐expressing Cells

Enhancement Of D1 Dopamine Receptor-Mediated Locomotor Stimulation In M-4 Muscarinic Acetylcholine Receptor Knockout Mice

Characterization of Dnajc12 knockout mice, a model of hypodopaminergia